首页 > 市场调查报告书 > 医疗设备

医院 IT 人工智能

市场调查报告书

商品编码

1606545

全球医疗保健聊天机器人市场 - 2024-2031

Global Healthcare Chatbots Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年，全球医疗保健聊天机器人市场规模达到6.8066亿美元，预计2031年将达到34.8866亿美元，2024-2031年预测期间复合年增长率为22.9%。

医疗聊天机器人也称为医疗保健聊天机器人，是一种人工智慧驱动的对话解决方案，旨在使医疗保健更具互动性和主动性。这些聊天机器人可以显着减少医务人员收集和处理患者资讯、传播医疗保健相关指南、确保患者参与等方面花费的时间，从而成为医疗保健系统的宝贵资产。

医疗保健聊天机器人充当患者与其医疗保健提供者之间的桥樑，通常是与诊所、医院或其他医疗保健组织的第一个联繫点。想像一下这样一个世界：您可以 24/7 随时获得个人化且高效的医疗保健支援。对于医疗保健聊天机器人的出现来说，这种情况并不是遥远的未来，而是当前的现实。这些人工智慧驱动的虚拟助理正在改变医疗保健提供者与患者互动、管理资料和优化营运的方式。

医疗保健聊天机器人配备了人工智慧、神经合成人工智慧和自然语言处理 (NLP)，正在彻底改变病患照护和管理效率。他们协助完成诸如设定预约提醒、促进文件提交以及提供持续的患者支援等任务。透过探索医疗保健聊天机器人领域，我们将了解它们如何不仅满足即时数位医疗保健互动的需求，而且在增强整个医疗保健行业方面发挥重要作用。这些因素推动了全球医疗保健聊天机器人市场的扩张。

市场动态：

驱动程式和限制

对虚拟健康援助的需求不断增加

对虚拟健康援助的需求不断增长，极大地推动了全球医疗保健聊天机器人市场的成长，预计将在整个市场预测期内推动成长。

消费者对医疗保健服务的态度发生了显着变化。根据 TechTarget 2024 年 10 月的资料，显示使用过虚拟医疗服务的消费者中有 94% 愿意继续使用这些选项。这种转变在年轻人群中尤其明显，43% 的千禧世代和 33% 的 Z 世代表示准备更换医疗保健提供者以改善虚拟就诊选项。这一趋势凸显了人们对虚拟医疗服务提供的便利性和可近性的强烈偏好。

这场大流行大大加速了虚拟医疗解决方案的采用。根据美国国家生物技术资讯中心 (NCBI) 2022 年 5 月的资料，远距医疗的使用量激增，报告显示，与疫情前的水平相比，远距医疗咨询量增加了 230% 以上。当患者体验到虚拟咨询的好处时，许多人发现它们是传统面对面咨询的实用替代方案。即使行动限制有所放鬆，对远距医疗服务的需求仍然很高，这表明这种转变可能是永久性的。

对于患者和提供者来说，虚拟医疗服务都更具成本效益。患者可以节省交通费用和下班时间，而医疗服务提供者可以减少与实体办公空间相关的间接费用。此外，虚拟健康可以帮助缩小获得医疗服务的差距，特别是在医疗设施可能有限的农村或服务不足的地区。

人工智慧聊天机器人等先进技术的整合透过立即回应患者询问、促进预约安排和提供症状评估来提高虚拟医疗服务的有效性。这些技术提高了患者参与度并简化了管理流程，使虚拟护理更有效率。所有这些因素都需要全球医疗保健聊天机器人市场。

此外，关键参与者的策略（例如伙伴关係和协作）将推动全球医疗保健聊天机器人市场的成长。例如，2024 年 7 月，GE 医疗保健与亚马逊网路服务 (AWS) 之间的合作标誌着人工智慧 (AI) 在医疗保健领域的整合取得了重大进展，特别是在增强诊断流程方面。这种合作至关重要，因为它符合利用人工智慧技术（包括聊天机器人）来改善患者护理和临床决策的日益增长的趋势。

此外，2024 年 9 月，Hackensack Meridian Health 与 K Health 合作推出 HMH 24/7 虚拟初级保健服务，这是全球医疗保健聊天机器人市场的重大发展。这项倡议凸显了人工智慧驱动的解决方案在医疗保健领域的日益集成，特别是在透过数位平台改善初级保健的可及性方面。所有这些因素都需要全球医疗保健聊天机器人市场。

此外，对人工智慧进步的需求不断增长有助于全球医疗保健聊天机器人市场的扩张。

资料隐私问题

资料隐私问题是全球医疗保健聊天机器人市场的一个重大限制，影响了这些技术的采用和实施。随着医疗保健聊天机器人变得越来越普遍，敏感患者资讯的管理引发了与安全性、合规性和可信性相关的关键问题。

医疗保健资料是最敏感的个人资讯类型之一。它包括病史、治疗计划和可识别健康资讯 (PHI) 等详细资讯。未经授权披露或不当处理这些资料可能会导致严重后果，包括身分盗窃、歧视和失去患者信任。由于聊天机器人通常需要存取这些敏感资料来提供个人化服务，因此确保其保护至关重要。

根据美国国家生物技术资讯中心 (NCBI) 2023 年 11 月的研究出版物，人工智慧聊天机器人的使用需要收集和储存大量个人资料，这引发了对资料安全和隐私的严重担忧。人工智慧模型的有效运作依赖于持续的机器学习，其中涉及持续将大型资料集输入回这些聊天机器人的神经网路中。如果用于训练聊天机器人的资料包含敏感的患者或业务讯息，它将成为未来互动中使用的资料集的一部分。因此，这些资料可能会洩露给有意和无意的受众，并在未经适当授权的情况下用于各种目的。

儘管人们认为人工智慧聊天机器人的能力有限，但它们具有巨大的潜力，可以从不同的资料来源收集新讯息，同时捕捉用户回应。随着越来越多的资料在网路上被收集和广泛共享，确保资料的安全性和机密性变得越来越具有挑战性。资讯量的不断增长增加了保护敏感资料免遭未经授权的存取或滥用的难度。

此外，人工智慧聊天机器人可能会透过互动无意中暴露敏感资讯。例如，如果使用者将机密健康详细资料或专有业务资讯输入聊天机器人，则存在这些资料可能被储存并随后被未经授权的方存取的风险。这种情况强调需要采取严格的安全措施来保护个人资讯并维持使用者对这些技术的信任。因此，上述因素可能会限制全球医疗保健聊天机器人市场的潜在成长。

A medical chatbots, also known as healthcare chatbots, is an AI-powered conversational solution designed to make healthcare more interactive and proactive. These chatbots serve as valuable assets to the healthcare system by significantly reducing the time medical staff spend on collecting and processing patient information, disseminating healthcare-related guidelines, ensuring patient engagement, and more.

Healthcare chatbots act as a bridge between patients and their healthcare providers, often serving as the first point of contact with clinics, hospitals, or other healthcare organizations. Imagine a world where healthcare support is available 24/7 at your fingertips, personalized and efficient. This scenario is not a distant future but a current reality, to the emergence of healthcare chatbots. These AI-powered virtual assistants are transforming how healthcare providers interact with patients, manage data, and optimize operations.

Equipped with AI, neuro-synthetic AI, and natural language processing (NLP), healthcare chatbots are revolutionizing patient care and administrative efficiency. They assist with tasks such as setting appointment reminders, facilitating document submissions, and providing continuous patient support. By exploring the realm of healthcare chatbots, we will see how they not only meet the demand for immediate digital healthcare interactions but also play a significant role in enhancing the overall healthcare industry. These factors have driven the global healthcare chatbots market expansion.

Market Dynamics: Drivers & Restraints

Increasing Demand for Virtual Health Assistance

The increasing demand for virtual health assistance is significantly driving the growth of the global healthcare chatbots market and is expected to drive throughout the market forecast period.

There has been a marked change in consumer attitudes towards healthcare delivery. According to the TechTarget data in October 2024, indicate that 94% of consumers who have utilized virtual health services are willing to continue using these options. This shift is especially pronounced among younger demographics, with 43% of millennials and 33% of Generation Z expressing readiness to switch healthcare providers for improved virtual visit options. This trend underscores a strong preference for the convenience and accessibility that virtual health services provide.

The pandemic significantly accelerated the adoption of virtual healthcare solutions. As per National Center for Biotechnology Information (NCBI) data in May 2022, telemedicine usage surged, with reports indicating increases of over 230% in telemedicine consultations compared to pre-pandemic levels. As patients experienced the benefits of virtual consultations, many found them to be a practical alternative to traditional in-person visits. Even as mobility restrictions have eased, the demand for telehealth services remains high, suggesting that this shift may be permanent.

Virtual health services can be more cost-effective for both patients and providers. Patients save on transportation costs and time away from work, while providers can reduce overhead costs associated with physical office space. Additionally, virtual health can help bridge gaps in access to care, particularly in rural or underserved areas where medical facilities may be limited.

The integration of advanced technologies such as AI chatbots enhances the effectiveness of virtual health services by providing immediate responses to patient inquiries, facilitating appointment scheduling, and offering symptom assessments. These technologies improve patient engagement and streamline administrative processes, making virtual care more efficient. All these factors demand the global healthcare chatbots market.

Furthermore, key players' strategies such as partnerships and collaborations would drive this global healthcare chatbots market growth. For instance, in July 2024, the partnership between GE HealthCare and Amazon Web Services (AWS) marks a significant advancement in the integration of artificial intelligence (AI) within the healthcare sector, particularly in the context of enhancing diagnostic processes. This collaboration is pivotal as it aligns with the growing trend of utilizing AI technologies, including chatbots, to improve patient care and clinical decision-making.

Also, in September 2024, the partnership between Hackensack Meridian Health and K Health to launch the HMH 24/7 virtual primary care service is a significant development in the global healthcare chatbot market. This initiative highlights the increasing integration of AI-driven solutions in healthcare, particularly in improving access to primary care through digital platforms. All these factors demand the global healthcare chatbots market.

Moreover, the rising demand for the advancements in artificial intelligence contributes to the global healthcare chatbots market expansion.

Data Privacy Concerns

Data privacy concerns are a significant restraint in the global healthcare chatbots market, impacting the adoption and implementation of these technologies. As healthcare chatbots become more widespread, the management of sensitive patient information raises critical issues related to security, compliance, and trustworthiness.

Healthcare data is among the most sensitive types of personal information. It includes details such as medical histories, treatment plans, and identifiable health information (PHI). Unauthorized disclosure or mishandling of this data can lead to severe consequences, including identity theft, discrimination, and loss of patient trust. Since chatbots often require access to this sensitive data to deliver personalized services, ensuring its protection is crucial.

According to the National Center for Biotechnology Information (NCBI) research publication in November 2023, the use of AI chatbots necessitates the collection and storage of vast amounts of personal data, which raises significant concerns regarding data security and privacy. The effective operation of AI models relies on continuous machine learning, which involves consistently inputting large datasets back into the neural networks of these chatbots. If the data used to train a chatbot includes sensitive patient or business information, it becomes part of the dataset utilized in future interactions. Consequently, this data could potentially be disclosed to both intended and unintended audiences and used for various purposes without proper authorization.

Despite the perception that AI chatbots have limited capabilities, they possess a substantial potential to gather and collect new information from diverse data sources while capturing user responses. As more data is collected and shared widely across the internet, ensuring data security and confidentiality becomes increasingly challenging. The growing volume of information raises the difficulty of protecting sensitive data from unauthorized access or misuse.

Moreover, AI chatbots can inadvertently expose sensitive information through their interactions. For instance, if users input confidential health details or proprietary business information into a chatbot, there is a risk that this data could be stored and later accessed by unauthorized parties. This situation emphasizes the need for stringent security measures to safeguard personal information and maintain user trust in these technologies. Thus, the above factors could be limiting the global healthcare chatbots market's potential growth.

Segment Analysis

The global healthcare chatbots market is segmented based on component, deployment, application, end-user, and region.

Component:

The software segment is expected to dominate the global healthcare chatbots market share

The software segment holds a major portion of the global healthcare chatbots market share and is expected to continue to hold a significant portion of the global healthcare chatbots market share during the forecast period.

The software segment is expected to maintain its leading position as healthcare providers increasingly recognize the value of chatbot solutions in enhancing patient engagement and streamlining operations. Healthcare chatbots software often features versatile application programming interfaces (APIs) that facilitate integration with existing healthcare systems, such as electronic health records (EHRs). This integration supports better data management and continuity of care. Many chatbot providers adopt subscription-based pricing structures, offering freemium versions that can be upgraded to premium plans. This model encourages widespread adoption while generating consistent revenue streams for developers.

The ongoing development of chatbot software is propelled by advanced technological features that enhance functionality. Natural Language Processing (NLP) This technology allows chatbots to better understand and interpret user queries, facilitating more natural and effective interactions. The ability to communicate in multiple languages increases the accessibility of chatbots, catering to diverse patient populations. With the rise in smartphone usage, chatbots are increasingly designed to function seamlessly across various mobile platforms, improving user convenience.

Furthermore, key players in the industry product launches that would drive this segment growth in the global healthcare chatbots market. For instance, in April 2023, Sensely Labs announced the integration of ChatGPT into its Front Door Navigator product. This development represents a significant enhancement in how insurance policyholders can interact with their insurance providers, enabling them to receive intuitive answers to their most pressing queries quickly and efficiently.

Also, in October 2023, the launch of ten new health chatbots represents a significant advancement in healthcare technology, aimed at improving the lives of millions by providing accessible, personalized health information and support. These chatbots leverage artificial intelligence (AI) to assist users in managing their health proactively and navigating complex healthcare systems.

Similarly, in October 2023, Mendel.ai launched a chatbot specifically aimed at helping users manage and access their medical records. This innovative tool is designed to simplify the process of retrieving health information, making it more straightforward for patients to comprehend their medical history and treatment options. By utilizing advanced AI technology, the chatbot offers personalized responses to user inquiries, thereby enhancing patient engagement and improving communication between patients and healthcare providers. These factors have solidified the segment's position in the global healthcare chatbots market.

Geographical Analysis

North America is expected to hold a significant position in the global healthcare chatbots market share

North America holds a substantial position in the global healthcare chatbots market and is expected to hold most of the market share.

The increasing demand for accessible and efficient healthcare services is a significant driver in the North American healthcare chatbots market. Patients expect immediate access to healthcare information and services, mirroring the convenience they experience in other sectors such as retail and banking. Healthcare chatbots cater to this demand by providing 24/7 availability, allowing patients to seek medical advice, schedule appointments, and receive follow-up care without delay. This capability addresses traditional barriers to healthcare access, such as office hours and geographical limitations.

By enabling patients to interact with chatbots for routine inquiries and appointment scheduling, healthcare providers can significantly reduce waiting times in clinics and hospitals. This efficiency enhances patient satisfaction and improves overall care delivery. The rapid advancement of artificial intelligence (AI) and natural language processing (NLP) technologies has made chatbots more capable of handling complex medical inquiries. These technologies allow chatbots to understand context, interpret user queries accurately, and provide personalized responses.

Furthermore, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, government initiatives & regulatory support, and product launches would propel this global healthcare chatbots market. For instance, in September 2023, HealthTap, a prominent virtual healthcare provider in the U.S., launched an enhanced version of its Dr.A.I. feature, which utilizes OpenAI's GPT-4 technology. This innovative tool is designed to streamline the patient interview process before medical appointments, enabling a more efficient and personalized healthcare experience.

Also, in September 2024, the International Myeloma Foundation (IMF) proudly launched Myelo, the first AI-powered responsive chatbot designed to serve as a virtual assistant for patients, care partners, and healthcare professionals dealing with multiple myeloma. This innovative tool aims to enhance the support and resources available to individuals affected by this complex disease.

Similarly, in April 2024, the Advanced Research Projects Agency for Health (ARPA-H) launched the Chatbot Accuracy and Reliability Evaluation (CARE) Exploration Topic (ET) to enhance the development and evaluation of chatbots used in patient-facing applications. This initiative is crucial given the increasing reliance on digital health tools, especially as more than half of American households utilize the Internet for health-related activities, including researching medical information. Thus, the above factors are consolidating the region's position as a dominant force in the global healthcare chatbots market.

Asia Pacific is growing at the fastest pace in the global healthcare chatbots market share

Asia Pacific holds the fastest pace in the global healthcare chatbots market and is expected to hold most of the market share.

The Asia-Pacific healthcare chatbots market is witnessing significant growth, primarily driven by rapid digitalization in the healthcare sector and advancements in artificial intelligence (AI) and natural language processing (NLP).

The healthcare landscape in the Asia-Pacific region is undergoing a profound transformation due to digitalization. This shift involves the adoption of digital technologies aimed at improving healthcare delivery, streamlining operations, and enhancing patient experiences. Healthcare chatbots are increasingly integrated into existing digital health platforms, enabling seamless communication between patients and providers. This integration enhances overall efficiency in healthcare delivery.

The continuous evolution of AI and NLP technologies significantly boosts the capabilities of healthcare chatbots. These advancements allow chatbots to provide more accurate and personalized health assistance, which is crucial in the diverse Asia-Pacific region. With advancements in NLP, chatbots can better comprehend and interpret complex medical inquiries. This capability enables them to respond accurately to patient questions, resulting in a more satisfying user experience.

Furthermore, in this region, key player's initiatives, key developments, and product launches would drive the global healthcare chatbots market growth. For instance, in March 2024, The Centre for Artificial Intelligence and Robotics (CAIR), part of the Chinese Academy of Sciences (CAS), developed a large language model-based chatbot specifically designed to assist doctors in making medical diagnoses and treatment decisions. This initiative reflects a growing trend in leveraging artificial intelligence to enhance healthcare delivery and improve clinical outcomes.

Also, in April 2024, Fortis Healthcare launched an AI-powered chatbot designed to assist individuals grappling with mental health challenges in India. Named "Adayu Mindfulness," the app offers psychological support akin to a first aid kit, specially tailored for those hesitant to seek professional help due to societal stigma. Stella, the AI chatbot embedded within the app, engages users in conversation and recommends self-assessment tools to help them understand their mental health status.

Similarly, in November 2024, the Ayushman Bharat Digital Mission (ABDM) launched a WhatsApp Chatbot designed to provide citizens with quick and easy access to healthcare information directly through the popular messaging platform. This initiative aims to enhance digital health guidance by making it readily available to users, thereby improving their ability to obtain essential health-related information.

Additionally, in June 2023, DocPlix launched Panini, an AI-powered chatbot specifically designed by doctors for doctors, aiming to enhance clinical practice by improving diagnostic precision, accelerating complex computations, and reducing medical judgment errors. The launch event was attended by over 250 top physicians in India, marking a significant milestone in the healthcare industry. Thus, the above factors are consolidating the region's position as the fastest-growing force in the global healthcare chatbots market.

Competitive Landscape

The major global players in the healthcare chatbots market include Your.MD Ltd., HealthTap, Inc., Sensely, Inc., Buoy Health, Inc., Infermedica, Ada Health GmbH, PACT Care BV., Woebot Health, GYANT, and Kenyt Inc. others.

Key Developments

In November 2024, HealthSci.AI launched a revolutionary suite of health-focused and biotech-driven chatbots designed to empower users with personalized guidance and support across a wide array of health and biotechnology topics. This initiative aims to create an accessible pathway for individuals to proactively manage their health and navigate the complexities of biotechnology with confidence.
In January 2024, Kauvery Hospital launched Floatbot, an advanced AI-driven chatbot on its website, aimed at enhancing patient care and engagement. This initiative reflects the growing trend of utilizing chatbot technology in the healthcare sector to automate various tasks and improve the overall patient experience. Floatbot simplifies the often-lengthy process of scheduling appointments. Patients can quickly book their visits through the chatbot, reducing wait times and streamlining administrative workflows for the hospital.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global healthcare chatbots market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Component
3.2. Snippet by Deployment
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Demand for Virtual Health Assistance
- 4.1.2. Restraints
  - 4.1.2.1. Data Privacy Concerns
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Component

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Component
- 6.1.2. Market Attractiveness Index, By Component
6.2. Software*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Services

7. By Deployment

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
- 7.1.2. Market Attractiveness Index, By Deployment
7.2. Cloud*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. On-Premise

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Symptom Checking*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Appointment Scheduling & Monitoring
8.4. Medical & Drug Information Assistance
8.5. Others

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Patients*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Insurance companies
9.4. Healthcare providers
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Your.MD Ltd. *
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. HealthTap, Inc.
12.3. Sensely, Inc.
12.4. Buoy Health, Inc.
12.5. Infermedica
12.6. Ada Health GmbH
12.7. PACT Care BV.
12.8. Woebot Health
12.9. GYANT
12.10. Kenyt Inc.

LIST NOT EXHAUSTIVE